FEBRUARY | Build the train -- then climb aboard

With the new year in full swing, it can be a challenge to plan and prioritize goals for the months ahead and map out a strategy for pursuing them. Consequently, sometimes it may feel like you're building the train while you're running alongside of it to climb aboard.

We've got good news -- you don't have to go on this journey alone

Bruder Consulting & Venture Group is made up of an innovative, knowledgeable team of experts with years of experience supporting and growing businesses at any point along their track -- with proven results. Take a look at our Client Partner Alexis Bio, for instance. It was recently awarded RMAT designation for its realSKIN™ therapy in severe burns. BCVG led the development of the regulatory strategy and approach, resulting in the first live cell xenotransplant product to receive RMAT designation.

To learn more about how BCVG can drive value for your novel therapeutic, check out our website. Plus, if you know someone who would benefit from this information, please forward this newsletter to them or 
invite them to subscribe via the BCVG website. Don't forget to follow us on LinkedIn, too. We’d love to start a conversation with you about the many ways we can work together.

Contact Us
Share Share
Tweet Tweet
Forward Forward
Share Share
NEWS WATCH: Regenerative medicine investments

BCVG is encouraged by the uptick in regenerative medicine investments. In January, this was exemplified by Zimmer Biomet's $275MM acquisition of Embody and Carmell Therapeutics' proposed $150MM recapitalization and merger agreement. These investments speak to the potential of regenerative technologies to drive value and transform patient care. 

Learn more about
this recent industry news, and visit bruderconsulting.com/transaction for more on BCVG's strategic partnering practice.

FYI: Industry updates & events

COMING SOON FROM AAOS: BCVG founder Dr. Scott Bruder is the lead editor, along with Dr. Roy Aaron, of the new book "Orthobiologics: Scientific and Clinical Solutions for Orthopaedic Surgeons." It will be available at the annual AAOS meeting in March, or preorder it now via the WK/AAOS online store, where members receive a 25% discount and free shipping.

ICYMI: Dr. Bruder lectured on Jan. 26 at the MSK Ultrasound and Orthobiologics course (orthosono.com) in Las Vegas. This presentation focused on his recent experience with the Department of Justice regarding his subpoenaed testimony in alleged False Claims Act violations. Watch a replay of the lecture HERE  

IOF MEETING: Dr. Bruder will be teaching at the 8th annual Interventional Orthobiologics Foundation meeting in Scottsdale, Arizona, on Feb. 16-19. Register now at interventionalorthobiologics.org 

ANNUAL AAOS MEETING: Dr. Bruder, along with BCVG Vice Presidents Jim Petricek and Dr. Susan Drapeau, will be at the Annual AAOS meeting from March 7-11 in Las Vegas. Dr. Bruder will be teaching several courses on the regulations and uses of Biologics, and the BCVG team will be available to discuss your product development or business transaction needs. Contact Dr. Bruder, Dr. Drapeau or Mr. Petricek to schedule a meeting. 
Here's what our Client Partners are saying ...

“Saol Therapeutics engaged with Bruder Consulting & Venture Group to assess the reimbursement landscape for our lead product candidates. BCVG's analysis and direction provided critical guidance for our program and overall commercialization strategy.”
-- Aaron Johnston, Senior Director of Strategic Marketing, Saol Therapeutics
Copyright © 2023 Bruder Consulting & Venture Group, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Bruder Consulting & Venture Group · 268 Glen Pl · Franklin Lakes, NJ 07417-2707 · USA

Email Marketing Powered by Mailchimp